LADENBURG THALMANN FINANCIAL SERVICES INC. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$90,000
-20.4%
10,557
-14.8%
0.00%0.0%
Q3 2019$113,000
-25.2%
12,389
-12.7%
0.00%0.0%
Q2 2019$151,000
+17.1%
14,189
+5.4%
0.00%0.0%
Q1 2019$129,000
-25.0%
13,462
-9.8%
0.00%
-50.0%
Q4 2018$172,000
-51.1%
14,929
-28.1%
0.00%
-33.3%
Q3 2018$352,000
+8.3%
20,762
+21.3%
0.00%0.0%
Q2 2018$325,0000.0%17,1120.0%0.00%0.0%
Q1 2018$325,000
+3.5%
17,112
-10.8%
0.00%0.0%
Q4 2017$314,000
+85.8%
19,189
+70.0%
0.00%
+50.0%
Q3 2017$169,000
+79.8%
11,289
+5.1%
0.00%
+100.0%
Q2 2017$94,000
+129.3%
10,740
+38.8%
0.00%0.0%
Q1 2017$41,000
+95.2%
7,740
+13.8%
0.00%
Q4 2016$21,0000.0%6,800
+51.1%
0.00%
Q3 2016$21,000
-19.2%
4,5000.0%0.00%
Q2 2016$26,000
-7.1%
4,500
-2.6%
0.00%
Q1 2016$28,000
-33.3%
4,6190.0%0.00%
-100.0%
Q4 2015$42,000
+110.0%
4,619
+27.6%
0.00%
Q3 2015$20,000
-50.0%
3,6190.0%0.00%
-100.0%
Q2 2015$40,000
-29.8%
3,6190.0%0.00%0.0%
Q1 2015$57,000
+3.6%
3,6190.0%0.00%0.0%
Q4 2014$55,000
+41.0%
3,6190.0%0.00%0.0%
Q3 2014$39,000
-29.1%
3,6190.0%0.00%
-50.0%
Q2 2014$55,000
-17.9%
3,619
-2.2%
0.00%0.0%
Q1 2014$67,000
+31.4%
3,7000.0%0.00%0.0%
Q4 2013$51,000
+2450.0%
3,700
+1750.0%
0.00%
Q3 2013$2,0000.0%2000.0%0.00%
Q2 2013$2,0002000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders